Characterization of CB1 receptors on rat neuronal cell cultures: Binding and functional studies using the selective receptor antagonist SR 141716A

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 402-409

  Jung, M ^a   Calassi, R ^a   Rinaldi Carmona, M ^a   Chardenot, P ^a   Le Fur, G ^a   Soubrie P ^a   Oury Donat, F ^a  

^a SANOFI   (France)

Author keywords

CB1 receptors; Cyclic AMP; Mitogen activated protein kinase; Primary neuronal cell cultures; SR 141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RIMONABANT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CELL; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031036959     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010402.x     Document Type: Article

References (35)

1. Badina H. and Greenberg M. E. (1991) Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253, 912-914.
2. Bidaut-Russell M., Devane W. A., and Hewlett A. C. (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in rat brain. J. Neurochem. 55, 21-26.
3. Bouaboula M., Poinot-Chazel C., Bourrié B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. (1995a) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312, 637-641.
4. Bouaboula M., Bourrié B., Rinaldi-Carmona M., Shire D., Le Fur G., and Casellas P. (1995b) Stimulation of cannabinoid receptor CB1 induces Krox-24 expression in human astrocytoma cells. J. Biol. Chem. 23, 13973-13980.
5. Caulfield M. P. and Brown D. A. (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106, 231-232.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3102.
7. Deadwyler S. A., Hampson R. E., Mu J., White A., and Childers S. (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273, 734-743.
8. Felder C. C., Veluz J. S., Williams H. L., Briley E. M., and Matsuda L. A. (1992) Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42, 838-845.
9. Felder C. C., Joyce K. E., Briley E. M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A. L., and Mitchell R. L. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48, 443-450.
10. Fiore R. S., Bayer V. E., Pelech S. L., Posada J., Cooper J. A., and Baraban J. M. (1993) p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendrites. Neuroscience 55, 463-472.
11. Frödin M., Peraldi P., and Van Obberghen E. (1994) Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem. 269, 6207-6214.
12. Gérard C., Mollereau C., Vassart G., and Parmentier M. (1991) Molecular cloning of a human brain cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
13. Glass M. and Dragunow M. (1995) Induction of the krox-24 transcription factor in striosomes by a cannabinoid agonist. Neuroreport 6, 241-244.
14. Gomez N. and Cohen P. (1991) Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353, 170-173.
15. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., De Costa B. R., and Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
16. Hollister L. E. (1992) Marijuana and immunity. J. Psychoactive Drugs 24, 159-164.
17. 2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters and serum quiescent cultured human fibroblasts. J. Biol. Chem. 263, 5396-5401.
18. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
19. Howlett A. C., Champion-Dorow T. M., McMahon L. L., and Westlake T. M. (1991) The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells. Pharmacol. Biochem. Behav. 40, 565-569.
20. Johnson B. A. (1990) Psychopharmacological effects of cannabis. Br. J. Hosp. Med. 43, 118-120.
21. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium current in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
22. Mailleux P. and Vanderhaeghen J. J. (1992a) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 44, 655-668.
23. Mailleux P. and Vanderhaeghen J. J. (1992b) Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci. Lett. 148, 173-176.
24. Matsuda L. A., Lolait S. T., Brownstein M. J., Young A. C., and Bonner T. I. (1990) Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
25. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
26. Pacheco M. A., Ward S. J., and Childers S. R. (1993) Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res. 603, 102-110.
27. Pertwee R. G. (1988) The central neuropharmacology of psychotropic cannabinoids. Pharmacol. Ther. 36, 189-261.
28. 1H]SR 141716A. Neuroreport 7, 789-792.
29. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J. C., and Le Fur G. (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
30. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrié P., Brelière J. C., and Le Fur G. (1995) Biochemical and pharmacological characterization of SR 141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56, 1941-1947.
31. 3H]SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci. 58, 1239-1247.
32. 9-tetrahydrocannabinol-evoked arachidonic acid mobilisation and blockade by SR 141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide hydrochloride]. Biochem. Pharmacol. 55, 669-676.
33. Song Z. H. and Bonner T. I. (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN 55212-2. Mol. Pharmacol. 49, 891-896.
34. Spector T. (1975) Refinement of the Coomassie Blue method of protein quantification. Anal. Biochem. 86, 142-146.
35. Wartmann M., Campbell D., Subramanian A., Burstein S. H., and Davis R. J. (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359, 133-136.